Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Gxv813
2. Ex-a8078
3. 2640099-21-2
4. Schembl23212952
5. Exa8078
6. Gxv-813
7. (7s)-7-[4-[5-fluoro-2-(2-oxaspiro[3.3]heptan-6-yloxy)phenyl]piperidin-1-yl]-2-(1,3,4-oxadiazol-2-yl)-5-oxa-2-azaspiro[3.4]octane
| Molecular Weight | 470.5 g/mol |
|---|---|
| Molecular Formula | C25H31FN4O4 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 73.1 |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 734 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
41
PharmaCompass offers a list of GXV813 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right GXV813 manufacturer or GXV813 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred GXV813 manufacturer or GXV813 supplier.
A GXV813 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GXV813, including repackagers and relabelers. The FDA regulates GXV813 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GXV813 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GXV813 supplier is an individual or a company that provides GXV813 active pharmaceutical ingredient (API) or GXV813 finished formulations upon request. The GXV813 suppliers may include GXV813 API manufacturers, exporters, distributors and traders.
GXV813 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GXV813 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right GXV813 GMP manufacturer or GXV813 GMP API supplier for your needs.
A GXV813 CoA (Certificate of Analysis) is a formal document that attests to GXV813's compliance with GXV813 specifications and serves as a tool for batch-level quality control.
GXV813 CoA mostly includes findings from lab analyses of a specific batch. For each GXV813 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GXV813 may be tested according to a variety of international standards, such as European Pharmacopoeia (GXV813 EP), GXV813 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GXV813 USP).
